Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

405
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
405
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

3.8K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.8K
Standards of Care II01:19

Standards of Care II

1.1K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.1K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

230
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
230
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

400
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
400
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

605
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
605

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MMW Fortschritte der Medizin·2025
Same author

To STRIDE or not to STRIDE: a critique of "treat to target" in ulcerative colitis.

Expert review of gastroenterology & hepatology·2024
Same author

To STRIDE or not to STRIDE: a critique of "treat to target" in Crohn´s disease.

Expert review of gastroenterology & hepatology·2023
Same author

Prioritization in inflammatory bowel disease therapy.

Expert review of gastroenterology & hepatology·2023
Same author

High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study.

Oncology research and treatment·2023
Same author

[JAK inhibitors - a new therapeutic option for inflammatory bowel disease].

MMW Fortschritte der Medizin·2022

Related Experiment Video

Updated: May 5, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

25.1K

Differences between treatment guidelines--Germany.

Klaus R Herrlinger1

  • 1Innere Medizin, Asklepios Klinik Nord, Betriebsteil Heidelberg, Hamburg, Germany.

Digestive Diseases (Basel, Switzerland)
|November 20, 2013
PubMed
Summary
This summary is machine-generated.

This review examines debated Crohn's disease treatments, including mesalamine, early anti-TNF therapy, and options for steroid-refractory patients, based on German Gastroenterology Association guidelines and evidence.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

11.6K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

1.0K

Related Experiment Videos

Last Updated: May 5, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

25.1K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

11.6K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

1.0K

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Clinical Practice Guidelines

Background:

  • Crohn's disease treatment guidelines involve significant debate.
  • Key areas include mesalamine efficacy, early anti-TNF antibody use, and managing steroid-refractory disease.

Purpose of the Study:

  • To critically evaluate debated treatment strategies for Crohn's disease.
  • To discuss these strategies in the context of German Gastroenterology Association (DGVS) statements and supporting evidence.

Main Methods:

  • Review of current scientific literature and clinical trial data.
  • Analysis of treatment guidelines, specifically those from the DGVS.
  • Evidence-based discussion of controversial therapeutic approaches.

Main Results:

  • Discussion focuses on three debated areas: mesalamine for mild-to-moderate Crohn's, early anti-TNF therapy, and treatment for steroid-refractory disease.
  • The role of anti-TNF antibodies and calcineurin inhibitors is examined for specific patient populations.

Conclusions:

  • Treatment decisions in Crohn's disease require careful consideration of evidence and guideline recommendations.
  • Further clarification on optimal therapeutic pathways for specific patient subgroups is warranted.